Objective: To analyze the effect of the characteristics of the donor and the preparation of donor graft in the success of Descemet's membrane endothelial keratoplasty (DMEK). Material and Methods: The patient and donor charts and the surgical videos of the cases that underwent DMEK between June 2017 and June 2020 were analyzed. Age, gender, diagnosis, Descemet's membrane (DM) attachment at the postoperative first week and the last visit from the patients' charts and age, gender, systemic diseases, and drugs from the donors' charts. The cases were divided into 2 groups; the cases with DM detachment (Group 1) and attached DM (Group 2) at the postoperative first week. Results: Fifty-three DMEK surgeries from 53 recipients with 53 DM grafts from 41 donors were analyzed. On the first postoperative week, DM was detached in 8 (15.1%, Group 1) cases and attached in 45 (84.9%, Group 2) cases. There were no statistically significant differences in the characteristics of the recipient or donor between groups. However, the amlodipine and doxazosin use of donors were found to be significantly higher in Group 1 (p=0.041, p=0.011; respectively). Conclusion: DM grafts may be used, regardless of the characteristics of the donor, in DMEK to compensate for the shortage of donors.
Keywords: Descemet's membrane endothelial keratoplasty; donor; graft adherence; systemic diseases
Amaç: Desme membran endotelyal keratoplasti (DMEK) başarısında donöre ait ve donör hazırlama sırasındaki özelliklerin etkisini değerlendirmektir. Gereç ve Yöntemler: Haziran 2017-Haziran 2020 tarihleri arasında DMEK uygulanan olgulara ait hasta kartları ve cerrahi videolar incelendi. Hasta kartlarından yaş, cinsiyet ve tanı kaydedildi. Ayrıca ameliyat sonrası 1. haftada ve son muayenede Desme membranının (DM) durumu (yatışık veya dekole) değerlendirildi. Donör yaşı, cinsiyeti, sistemik hastalıkları ve kullandığı sistemik ilaç bilgileri donörün hastane dosyasından elde edildi. Olgular, ameliyat sonrası 1. haftada, DM dekolmanı olan (1. Grup) ve DM yatışık olan (2. Grup) olarak 2 gruba ayrıldı. Bulgular: Kırk bir donöre ait 53 DM greft ile DMEK uygulanan 53 olgunun 53 gözü çalışmaya dâhil edildi. Ameliyat sonrası 1. haftada DM 8 (%15,1, 1. Grup) olguda dekole, 45 (%84,9, 2. Grup) olguda ise yatışık olarak izlendi. Gruplar arasında alıcı ve donör özellikleri açısından istatistiksel olarak anlamlı fark saptanmadı. Ancak donörlerde amlodipin ve doksazosin kullanımı 1. Grupta anlamlı olarak fazla bulundu (p=0,041, p=0,011; sırasıyla). Sonuç: Donör eksikliği göz önünde bulundurulduğunda, DM greftleri, donör özelliklerine bakılmaksızın DMEK'de kullanılabili
Anahtar Kelimeler: Desme membran endotelyal keratoplasti; donör; greft yatışıklığı; sistemik hastalıklar
- Melles GR. Posterior lamellar keratoplasty: DLEK to DSEK to DMEK. Cornea. 2006;25(8):879-81. [Crossref] [PubMed]
- Deng SX, Lee WB, Hammersmith KM, Kuo AN, Li JY, Shen JF, et al. Descemet membrane endothelial keratoplasty: safety and outcomes: a report by the American Academy of Ophthalmology. Ophthalmology. 2018;125(2):295-310. [Crossref] [PubMed]
- Price MO, Gupta P, Lass J, Price FW Jr. EK (DLEK, DSEK, DMEK): New frontier in cornea surgery. Annu Rev Vis Sci. 2017;3:69-90. [Crossref] [PubMed]
- Vislisel JM, Liaboe CA, Wagoner MD, Goins KM, Sutphin JE, Schmidt GA, et al. Graft survival of diabetic versus nondiabetic donor tissue after initial keratoplasty. Cornea. 2015;34(4):370-4. [Crossref] [PubMed]
- Price MO, Thompson RW Jr, Price FW Jr. Risk factors for various causes of failure in initial corneal grafts. Arch Ophthalmol. 2003;121(8):1087-92. [Crossref] [PubMed]
- Price MO, Lisek M, Feng MT, Price FW Jr. Effect of donor and recipient diabetes status on descemet membrane endothelial keratoplasty adherence and survival. Cornea. 2017;36(10):1184-8. [Crossref] [PubMed]
- Groeneveld-van Beek EA, Lie JT, van der Wees J, Bruinsma M, Melles GR. Standardized 'no-touch' donor tissue preparation for DALK and DMEK: harvesting undamaged anterior and posterior transplants from the same donor cornea. Acta Ophthalmol. 2013;91(2):145-50. [Crossref] [PubMed]
- Dapena I, Moutsouris K, Droutsas K, Ham L, van Dijk K, Melles GR. Standardized "no-touch" technique for descemet membrane endothelial keratoplasty. Arch Ophthalmol. 2011;129(1):88-94. [Crossref] [PubMed]
- Koçluk Y, Kasım B, Sukgen EA, Burcu A. Descemet membrane endothelial keratoplasty (DMEK): intraoperative and postoperative complications and clinical results. Arq Bras Oftalmol. 2018;81(3):212-8. [Crossref] [PubMed]
- Heinzelmann S, Hüther S, Böhringer D, Eberwein P, Reinhard T, Maier P. Influence of donor characteristics on descemet membrane endothelial keratoplasty. Cornea. 2014;33(6):644-8. [Crossref] [PubMed]
- Baydoun L, Ham L, Borderie V, Dapena I, Hou J, Frank LE, et al. Endothelial survival after descemet membrane endothelial keratoplasty: effect of surgical ındication and graft adherence status. JAMA Ophthalmol. 2015;133(11):1277-85. [Crossref] [PubMed]
- Anshu A, Price MO, Price FW. Descemet's stripping endothelial keratoplasty: long-term graft survival and risk factors for failure in eyes with preexisting glaucoma. Ophthalmology. 2012;119(10):1982-7. [Crossref] [PubMed]
- Ang M, Sng CCA. Descemet membrane endothelial keratoplasty and glaucoma. Curr Opin Ophthalmol. 2018;29(2):178-84. [Crossref] [PubMed]
- Treder M, Alnawaiseh M, Eter N. Descemet membrane endothelial keratoplasty (DMEK) early stage graft failure in eyes with preexisting glaucoma. Graefes Arch Clin Exp Ophthalmol. 2017;255(7):1417-21. [Crossref] [PubMed]
- Greiner MA, Rixen JJ, Wagoner MD, Schmidt GA, Stoeger CG, Straiko MD, et al. Diabetes mellitus increases risk of unsuccessful graft preparation in Descemet membrane endothelial keratoplasty: a multicenter study. Cornea. 2014;33(11):1129-33. [Crossref] [PubMed]
- Vianna LM, Stoeger CG, Galloway JD, Terry M, Cope L, Belfort R Jr, et al. Risk factors for eye bank preparation failure of Descemet membrane endothelial keratoplasty tissue. Am J Ophthalmol. 2015;159(5):829-34.e2. [Crossref] [PubMed] [PMC]
- Green K, Cheeks L, Hull DS. Effects of calcium channel blockers on rabbit corneal endothelial function. Curr Eye Res. 1994;13(6):401-8. [Crossref] [PubMed]
- Müskens RP, de Voogd S, Wolfs RC, Witteman JC, Hofman A, de Jong PT, et al. Systemic antihypertensive medication and incident open-angle glaucoma. Ophthalmology. 2007;114(12):2221-6. [Crossref] [PubMed]
- Zheng W, Dryja TP, Wei Z, Song D, Tian H, Kahler KH, et al. Systemic medication associations with presumed advanced or uncontrolled primary open-angle glaucoma. Ophthalmology. 2018;125(7):984-93. [Crossref] [PubMed]
.: Process List